<VariationArchive VariationID="2445975" VariationName="NM_020812.4(DOCK6):c.3180del (p.Cys1061fs)" VariationType="Deletion" Accession="VCV002445975" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-12" DateCreated="2023-03-26" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2418926" VariationID="2445975">
      <GeneList>
        <Gene Symbol="DOCK6" FullName="dedicator of cytokinesis 6" GeneID="57572" HGNC_ID="HGNC:19189" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11199295" stop="11262524" display_start="11199295" display_stop="11262524" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11309968" stop="11373167" display_start="11309968" display_stop="11373167" Strand="-" />
          </Location>
          <OMIM>614194</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020812.4(DOCK6):c.3180del (p.Cys1061fs)</Name>
      <CanonicalSPDI>NC_000019.10:11222794:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11222795" stop="11222795" display_start="11222795" display_stop="11222795" variantLength="1" positionVCF="11222794" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11333471" stop="11333471" display_start="11333471" display_stop="11333471" variantLength="1" positionVCF="11333470" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>C1061fs</ProteinChange>
      <ProteinChange>C1096fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.11222798del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.11222798del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.11333474del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.11333474del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031953.1" sequenceAccession="NG_031953" sequenceVersion="1" change="g.44698del">
            <Expression>NG_031953.1:g.44698del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367830.1" sequenceAccession="NM_001367830" sequenceVersion="1" change="c.3285del">
            <Expression>NM_001367830.1:c.3285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354759.1" sequenceAccession="NP_001354759" sequenceVersion="1" change="p.Cys1096fs">
            <Expression>NP_001354759.1:p.Cys1096fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020812.4" sequenceAccession="NM_020812" sequenceVersion="4" change="c.3180del" MANESelect="true">
            <Expression>NM_020812.4:c.3180del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065863.2" sequenceAccession="NP_065863" sequenceVersion="2" change="p.Cys1061fs">
            <Expression>NP_065863.2:p.Cys1061fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020812.3" sequenceAccession="NM_020812" sequenceVersion="3" change="c.3180delC">
            <Expression>NM_020812.3:c.3180delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020812.4(DOCK6):c.3180del (p.Cys1061fs) AND Adams-Oliver syndrome 2" Accession="RCV003155894" Version="1">
        <ClassifiedConditionList TraitSetID="7604">
          <ClassifiedCondition DB="MedGen" ID="C3280182">Adams-Oliver syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020812.4(DOCK6):c.3180del (p.Cys1061fs) AND DOCK6-related disorder" Accession="RCV003396929" Version="4">
        <ClassifiedConditionList TraitSetID="89935">
          <ClassifiedCondition>DOCK6-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-03-26" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7604" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16531" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome 2</ElementValue>
                <XRef ID="Adams-Oliver+syndrome+2/7632" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013635" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOS2</ElementValue>
                <XRef Type="MIM" ID="614219" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15775" />
                <XRef ID="15775" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C3280182" DB="MedGen" />
              <XRef ID="MONDO:0013635" DB="MONDO" />
              <XRef Type="MIM" ID="614219" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89935" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70282" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DOCK6-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">DOCK6-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7183419" SubmissionDate="2023-03-16" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="NM_020812.3:c.3180delC|MedGen:C3280182" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003844231" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: DOCK6 c.3180delC (p.Cys1061AlafsX33) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.3190_3191del [p.Leu1064fs], c.4012C&gt;T [p.Arg1338Ter]). The variant was absent in 205698 control chromosomes (gnomAD). To our knowledge, no occurrence of c.3180delC in individuals affected with Adams-Oliver Syndrome 2 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DOCK6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020812.3:c.3180delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280182" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12956415</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7688195" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="36388472|DOCK6-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004105113" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The DOCK6 c.3180delC variant is predicted to result in a frameshift and premature protein termination (p.Cys1061Alafs*33). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in DOCK6 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DOCK6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020812.3:c.3180delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DOCK6-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7183419" TraitType="Disease" MappingType="XRef" MappingValue="C3280182" MappingRef="MedGen">
        <MedGen CUI="C3280182" Name="Adams-Oliver syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7688195" TraitType="Disease" MappingType="Name" MappingValue="DOCK6-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="DOCK6-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

